GAS6 and diabetic kidney disease: Loss of Gas6 protected against glomerular proliferation, sclerosis and proteinuria in the nephrotoxic nephritis model [12] and reduced mesangial hypertrophy in streptozotocin-induced diabetic nephropathy [11].